Literature DB >> 1410175

Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis.

E M Ornitz1, G L Hanna, J de Traversay.   

Abstract

Startle modulation was induced by prestimulation in 43, 6-11 year old boys with attention-deficit hyperactivity disorder (ADHD), 13 of whom were or had been enuretic, 17 age-matched enuretic boys, and 42 age-matched normal boys, using 60-ms and 120-ms prestimulation intervals and a 4000-ms continuous tone. There was a significant multivariate effect of enuresis on startle amplitude modulation. This effect was attributed primarily to the reduction of amplitude inhibition following the 120-ms prestimulation interval regardless of whether or not enuresis was associated with ADHD. There was no effect of ADHD on startle modulation by prestimulation. The inhibition following the 120-ms prestimulation interval in the enuretic boys was reduced to the level of 5-year-old normal children, suggesting a maturational component of the deficient startle inhibition. The neurophysiologic dysfunction underlying the deficient startle inhibition in enuresis, but not ADHD, is discussed in terms of a possible dysfunction of mesopontine reticular mechanisms mediating preattentive processing of signals associated with spinal reflexes involved in urinary bladder control.

Entities:  

Mesh:

Year:  1992        PMID: 1410175     DOI: 10.1111/j.1469-8986.1992.tb01717.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  28 in total

1.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 2.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

3.  Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder.

Authors:  Rebecca L Ashare; Larry W Hawk; Keri Shiels; Jessica D Rhodes; William E Pelham; James G Waxmonsky
Journal:  Psychophysiology       Date:  2010-03-10       Impact factor: 4.016

4.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

5.  Prepulse inhibition of startle in adults with ADHD.

Authors:  David Feifel; Arpi Minassian; William Perry
Journal:  J Psychiatr Res       Date:  2008-07-31       Impact factor: 4.791

Review 6.  Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.

Authors:  Neal R Swerdlow
Journal:  Neurosci Biobehav Rev       Date:  2012-09-24       Impact factor: 8.989

7.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

8.  Cerebellar α6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

Authors:  Lih-Chu Chiou; Hsin-Jung Lee; Margot Ernst; Wei-Jan Huang; Jui-Feng Chou; Hon-Lie Chen; Akihiro Mouri; Liang-Chieh Chen; Marco Treven; Takayoshi Mamiya; Pi-Chuan Fan; Daniel E Knutson; Chris Witzigmann; James Cook; Werner Sieghart; Toshitaka Nabeshima
Journal:  Br J Pharmacol       Date:  2018-05-10       Impact factor: 8.739

9.  Startle modulation studies in autism.

Authors:  E M Ornitz; S J Lane; T Sugiyama; J de Traversay
Journal:  J Autism Dev Disord       Date:  1993-12

10.  Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD?

Authors:  Judith Sinzig; Dagmar Morsch; Gerd Lehmkuhl
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.